Below are the most recent publications written about "Erythema" by people in Profiles.
-
Garza-Mayers AC, Su KA, Wiss K. Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser. Pediatr Dermatol. 2022 Nov; 39(6):1005-1006.
-
Wormser GP, McKenna D, Jacobson E, Shanker EM, Shaffer KD, Scavarda C, Visintainer P. Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment. Antimicrob Agents Chemother. 2020 12 16; 65(1).
-
Wormser GP, McKenna D, Karmen CL, Shaffer KD, Silverman JH, Nowakowski J, Scavarda C, Shapiro ED, Visintainer P. Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months. Clin Infect Dis. 2020 12 15; 71(12):3118-3124.
-
Franciosi E, Blankenship K, Houk L, Rashighi M. Ovoid palatal patch: a clue to anti-TIF1? dermatomyositis. BMJ Case Rep. 2020 Apr 23; 13(4).
-
Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease. Clin Infect Dis. 2015 Dec 15; 61(12):1800-6.
-
Mahmoud BH, Burnett C, Ozog D. Prospective randomized controlled study to determine the effect of topical application of botulinum toxin A for crow's feet after treatment with ablative fractional CO2 laser. Dermatol Surg. 2015 Jan; 41 Suppl 1:S75-81.
-
Moore LA, Kaufman MD, Algozzine R, Irish N, Martin M, Posey CR. Adherence to therapy: using an evidence-based protocol. Rehabil Nurs. 2007 Nov-Dec; 32(6):227-32.
-
Frey SE, Newman FK, Kennedy JS, Sobek V, Ennis FA, Hill H, Yan LK, Chaplin P, Vollmar J, Chaitman BR, Belshe RB. Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge. Vaccine. 2007 Dec 12; 25(51):8562-73.
-
Golding J. Two students, 2 tropical beaches, 2 injured feet. J Fam Pract. 2006 Sep; 55(9):773-4.
-
Gordinier ME, Dizon DS, Fleming EL, Weitzen S, Schwartz J, Parker LP, Granai CO. Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin. Gynecol Oncol. 2006 Oct; 103(1):72-4.